228 related articles for article (PubMed ID: 18623218)
1. Clofarabine in refractory Langerhans cell histiocytosis.
Rodriguez-Galindo C; Jeng M; Khuu P; McCarville MB; Jeha S
Pediatr Blood Cancer; 2008 Nov; 51(5):703-6. PubMed ID: 18623218
[TBL] [Abstract][Full Text] [Related]
2. Clofarabine salvage therapy for refractory high-risk langerhans cell histiocytosis.
Abraham A; Alsultan A; Jeng M; Rodriguez-Galindo C; Campbell PK
Pediatr Blood Cancer; 2013 Jun; 60(6):E19-22. PubMed ID: 23255383
[TBL] [Abstract][Full Text] [Related]
3. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.
Simko SJ; Tran HD; Jones J; Bilgi M; Beaupin LK; Coulter D; Garrington T; McCavit TL; Moore C; Rivera-Ortegón F; Shaffer L; Stork L; Turcotte L; Welsh EC; Hicks MJ; McClain KL; Allen CE
Pediatr Blood Cancer; 2014 Mar; 61(3):479-87. PubMed ID: 24106153
[TBL] [Abstract][Full Text] [Related]
4. Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis.
Parekh D; Lin H; Batajoo A; Peckham-Gregory E; Karri V; Stanton W; Scull B; Fleishmann R; El-Mallawany N; Eckstein OS; Prudowsky ZD; Gulati N; Agrusa JE; Ahmed AZ; Chu R; Dietz MS; Goldman SC; Hogarty MD; Imran H; Intzes S; Kim JM; Kopp LM; Levy CF; Neff P; Pillai PM; Sisk BA; Schiff DE; Trobaugh-Lotrario AD; Walkovich K; McClain KL; Allen CE
Br J Haematol; 2024 May; 204(5):1888-1893. PubMed ID: 38501389
[TBL] [Abstract][Full Text] [Related]
5. Clofarabine for the treatment of acute lymphoblastic leukemia.
Jeha S; Kantarjian H
Expert Rev Anticancer Ther; 2007 Feb; 7(2):113-8. PubMed ID: 17288522
[TBL] [Abstract][Full Text] [Related]
6. Clofarabine for the treatment of adult acute myeloid leukemia.
Thomas X; Raffoux E; Elhamri M; Lobe I; Cannas G; Dombret H
Future Oncol; 2009 Oct; 5(8):1197-210. PubMed ID: 19852733
[TBL] [Abstract][Full Text] [Related]
7. Clofarabine: a new treatment option for patients with acute myeloid leukemia.
Larson ML; Venugopal P
Expert Opin Pharmacother; 2009 Jun; 10(8):1353-7. PubMed ID: 19463072
[TBL] [Abstract][Full Text] [Related]
8. Clofarabine in pediatric acute leukemia: current findings and issues.
Hijiya N; Barry E; Arceci RJ
Pediatr Blood Cancer; 2012 Sep; 59(3):417-22. PubMed ID: 22354543
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study.
Styczynski J; Gil L; Derwich K; Wachowiak J; Balwierz W; Badowska W; Krawczuk-Rybak M; Matysiak M; Wieczorek M; Balcerska A; Sonta-Jakimczyk D; Stefaniak J; Kowalczyk J; Urasinski T; Sobol G; Komarnicki M; Wysocki M
Anticancer Res; 2009 May; 29(5):1643-50. PubMed ID: 19443380
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Jeha S; Gaynon PS; Razzouk BI; Franklin J; Kadota R; Shen V; Luchtman-Jones L; Rytting M; Bomgaars LR; Rheingold S; Ritchey K; Albano E; Arceci RJ; Goldman S; Griffin T; Altman A; Gordon B; Steinherz L; Weitman S; Steinherz P
J Clin Oncol; 2006 Apr; 24(12):1917-23. PubMed ID: 16622268
[TBL] [Abstract][Full Text] [Related]
11. Multiply relapsed mixed histiocytosis in an adult responding to clofarabine after failure of cladribine.
Othman J; Bonar F; Brown W; Boyle R; Khoo TL
Leuk Lymphoma; 2020 Feb; 61(2):477-480. PubMed ID: 31483174
[No Abstract] [Full Text] [Related]
12. Clofarabine and nelarabine: two new purine nucleoside analogs.
Gandhi V; Plunkett W
Curr Opin Oncol; 2006 Nov; 18(6):584-90. PubMed ID: 16988579
[TBL] [Abstract][Full Text] [Related]
13. Clofarabine (2-chloro-2'-fluoro-2'-deoxyarabinosyladenine)--biochemical aspects of anticancer activity.
Majda K; Lubecka K; Kaufman-Szymczyk A; Fabianowska-Majewska K
Acta Pol Pharm; 2011; 68(4):459-66. PubMed ID: 21796927
[TBL] [Abstract][Full Text] [Related]
14. Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia.
O'Connor D; Sibson K; Caswell M; Connor P; Cummins M; Mitchell C; Motwani J; Taj M; Vora A; Wynn R; Kearns PR
Br J Haematol; 2011 Aug; 154(4):482-5. PubMed ID: 21689087
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in the treatment of acute lymphoblastic leukemia: clofarabine.
Jeha S
Hematol Oncol Clin North Am; 2009 Oct; 23(5):1137-44, viii. PubMed ID: 19825457
[TBL] [Abstract][Full Text] [Related]
16. Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults.
Tran H; Yang D
Ann Pharmacother; 2012 Jan; 46(1):89-96. PubMed ID: 22170975
[TBL] [Abstract][Full Text] [Related]
17. Clofarabine induced durable complete remission in heavily pretreated adolescents with relapsed and refractory leukemia.
Steinherz PG; Meyers PA; Steinherz LJ; Jeha S
J Pediatr Hematol Oncol; 2007 Sep; 29(9):656-8. PubMed ID: 17805046
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.
Jeha S; Razzouk B; Rytting M; Rheingold S; Albano E; Kadota R; Luchtman-Jones L; Bomgaars L; Gaynon P; Goldman S; Ritchey K; Arceci R; Altman A; Stine K; Steinherz L; Steinherz P
J Clin Oncol; 2009 Sep; 27(26):4392-7. PubMed ID: 19652076
[TBL] [Abstract][Full Text] [Related]
19. Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
Lech-Maranda E; Korycka A; Robak T
Mini Rev Med Chem; 2009 Jun; 9(7):805-12. PubMed ID: 19519505
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic effect of clofarabine in children with relapsed or refractory acute lymphoblastic leukemia].
Suo P; Zhang LP; Wu J; Lu AD; Wang B; Zuo YX; Cheng YF; Liu GL
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):444-7. PubMed ID: 23791059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
